Revolutionizing Neuro-care
With AI
Affordable AI-powered Alzheimer's care, anywhere, anytime.
Engineers and Advisors from:
Stakeholders From:
Affordable AI-powered Alzheimer's care, anywhere, anytime.
Remote data inputs for Alzheimer's care, AI driven assessment with personalization, and enhanced healthcare standards.
The market potential for NeuraVia in the Alzheimer’s sector is substantial, with significant opportunities for growth and expansion. With a total market value of approximately $6 billion and a current share of market (SOM) of $50 million, NeuraVia is well-positioned to broaden its consumer reach and strengthen its presence as our development and commercialization strategies advance.
NeuraVia began as a nonprofit initiative improving access to neurological care worldwide.
We’ve since incorporated as a Delaware C-Corp and are now scaling our AI-driven Alzheimer’s care platform globally.
Strategic partnerships in Nigeria and India are helping us expand market adoption in underserved regions.
Our advisory board includes experts from Google, Amazon, and global healthcare institutions as we raise a $500K pre-seed to advance product development.
NeuraVia transforms Alzheimer’s care by connecting patients, doctors, and innovators through data-driven insights and personalized treatment support.
Empowers individuals and families with real-time progress tracking, memory support tools, and personalized care insights.
Provides clinicians with AI-driven diagnostics and patient analytics to enhance precision in Alzheimer’s treatment planning.
Optimizes operations and resource allocation through predictive insights, improving care outcomes and cost efficiency.
Accelerates Alzheimer’s drug development by leveraging aggregated, anonymized patient data to identify treatment breakthroughs.
Learn more about how NeuraVia supports early Alzheimer’s detection and personalized care with AI-powered tools.
Join NeuraVia in revolutionizing brain health through accessible, AI-powered Alzheimer’s care. Together, we’re making neuro-care affordable, global, and human.
Invest in NeuraVia© 2025 NeuraVia, Inc. All rights reserved.